
OLD Category: immuno-oncology
August 4, 2017 / Clin. Can. Res.
Combination therapy with NHS-muIL12 and avelumab (anti-PD-L1) enhances antitumor efficacy in preclinical cancer models
August 4, 2017 / Nature Commun.
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
June 26, 2017 / Journal of Clinical Investigation
Gene expression profile predicts response to pembrolizumab
June 26, 2017 / Journal of Clinical Investigation (JCI)
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
May 11, 2017 / Cytotherapy
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function
May 9, 2017 / Stem Cell Reports